CLOSE| Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| Feb 16, 2024 |
Director
Trans History: 57
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 93,506 |
| Feb 16, 2024 |
Director
Trans History: 22
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 111,936 |
| Feb 16, 2024 |
Director
Trans History: 66
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 46,925 |
| Feb 16, 2024 |
Director
Trans History: 7
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 70,943 |
| Feb 16, 2024 |
Director
Trans History: 98
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 9,247 | -- | 100,298 |
| Feb 15, 2024 |
EVP,General Counsel, Secretary
Trans History: 39
|
EVP,General Counsel, Secretary | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,868 | -- | 214,685 |
| Feb 15, 2024 |
Chief Human Resources
Trans History: 16
|
Chief Human Resources | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 36,166 | -- | 274,911 |
| Feb 15, 2024 |
Chief Human Resources
Trans History: 16
|
Chief Human Resources | Form 4 | Open market or private sale of non-derivative or derivative security | 30,000 | $14.25 | 244,911 |
| Feb 15, 2024 |
EVP & Chief Financial Officer
Trans History: 153
|
EVP & Chief Financial Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 38,799 | -- | 363,970 |
| Feb 15, 2024 |
EVP, Chief Development Officer
Trans History: 186
|
EVP, Chief Development Officer | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 38,799 | -- | 184,271 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.